First Serbian patient to receive Russian cancer vaccine in August 2026

A patient in Serbia is scheduled to begin treatment with a Russian-developed cancer vaccine in late August 2026. The efficacy and clinical trial status of this specific vaccine remain unverified by international health authorities, leaving its broader medical impact uncertain.